StockData
Nuo Therapeutics, Inc. logo

Nuo Therapeutics, Inc. (AURX) income statement

AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 8/30
$1.26−0.04 (-3.08%)

Close on Oct 19, 2026Market cap $60.99MP/E –Yield –

Nuo Therapeutics, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
64.1%
Operating margin
-33.3%
Net margin
-38.7%
Return on equity, FY2025
1134.6%

Financial strength

Current ratio
1.28
Debt to equity
–
Debt to assets
–
Cash to current liabilities
28.9%

Valuation

P/E ratio
–
Price to sales
11.73
Price to book
–
Dividend yield
–

See a number that looks wrong?